Rankings
▼
Calendar
REVB Q2 2020 Earnings — Revelation Biosciences, Inc. Revenue & Financial Results | Market Cap Arena
REVB
Revelation Biosciences, Inc.
$2M
Q2 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$164,877
Net Income
-$164,877
EPS (Diluted)
$-0.50
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$130,349
Free Cash Flow
-$130,349
Stock-Based Comp.
$0
← FY 2020
All Quarters
Q3 2020 →
